These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36827118)

  • 1. A Comparative Study of Oncolytic Vaccinia Viruses Harboring Different Marine Lectins in Breast Cancer Cells.
    Zhou Y; Wang Q; Ying Q; Zhang X; Ye T; Chen K; Li G
    Mar Drugs; 2023 Jan; 21(2):. PubMed ID: 36827118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Oncolytic Vaccinia Viruses Harboring Different Marine Lectins on Hepatocellular Carcinoma Cells.
    Zhou Y; Wang Q; Ying Q; Zhang X; Chen K; Ye T; Li G
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncolytic Vaccinia Virus Carrying
    Zheng X; Xu W; Ying Q; Ni J; Jia X; Zhou Y; Ye T; Li G; Chen K
    Mar Drugs; 2022 Oct; 20(11):. PubMed ID: 36354990
    [No Abstract]   [Full Text] [Related]  

  • 4. Oncolytic Vaccinia Virus Harboring
    Jiang R; Qiu Y; Zhang X; Zhou N; Jia X; Chen K; Zhou Y; Ye T; Li G
    Mar Drugs; 2022 Jun; 20(6):. PubMed ID: 35736181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncolytic Vaccinia Virus Expressing
    Wu T; Xiang Y; Liu T; Wang X; Ren X; Ye T; Li G
    Mar Drugs; 2019 Jun; 17(6):. PubMed ID: 31248066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncolytic Vaccinia Virus Expressing White-Spotted Charr Lectin Regulates Antiviral Response in Tumor Cells and Inhibits Tumor Growth In Vitro and In Vivo.
    Wang X; Zhou N; Liu T; Jia X; Ye T; Chen K; Li G
    Mar Drugs; 2021 May; 19(6):. PubMed ID: 34064193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncolytic vaccinia virus harboring aphrocallistes vastus lectin exerts anti-tumor effects by directly oncolysis and inducing immune response through enhancing ROS in human ovarian cancer.
    Zhang G; Wang Q; Yuan R; Zhang Y; Chen K; Yu J; Ye T; Jia X; Zhou Y; Li G; Chen K
    Biochem Biophys Res Commun; 2024 Oct; 730():150355. PubMed ID: 38996784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ROS Induced by
    Zhang Y; Zhu Y; Jiang G; Chen K; Zhang G; Chen K; Ye T; Zhou Y; Li G
    Mar Drugs; 2024 Jun; 22(7):. PubMed ID: 39057416
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Li G; Cheng J; Mei S; Wu T; Ye T
    Mar Drugs; 2018 Jun; 16(6):. PubMed ID: 29880736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncolytic Vaccinia Virus Harboring
    Ni J; Feng H; Xu X; Liu T; Ye T; Chen K; Li G
    Mar Drugs; 2021 Sep; 19(10):. PubMed ID: 34677432
    [No Abstract]   [Full Text] [Related]  

  • 11. AVL-armed oncolytic vaccinia virus promotes viral replication and boosts antitumor immunity via increasing ROS levels in pancreatic cancer.
    Yu J; An N; Zhu J; Zhu B; Zhang G; Chen K; Zhou Y; Ye T; Li G
    Mol Ther Oncol; 2024 Dec; 32(4):200878. PubMed ID: 39431173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncolytic Vaccinia Virus Encoding
    Zhu B; Hong Z; Zhu J; Yu J; Zhou Y; Chen K; Ye T; Li G
    Hum Gene Ther; 2024 Nov; 35(21-22):938-950. PubMed ID: 39318235
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Li G; Mei S; Cheng J; Wu T; Luo J
    Mar Drugs; 2018 Apr; 16(5):. PubMed ID: 29701680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncolytic vaccinia virus harboring
    Gao C; Ying Q; Qiu Y; Ren N; Chen K; Zhou Y; Ye T; Li G
    Mol Ther Oncol; 2024 Sep; 32(3):200823. PubMed ID: 39006946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncolytic and immunologic cancer therapy with GM-CSF-armed vaccinia virus of Tian Tan strain Guang9.
    Deng L; Fan J; Guo M; Huang B
    Cancer Lett; 2016 Mar; 372(2):251-7. PubMed ID: 26803055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncolytic efficacy of thymidine kinase-deleted vaccinia virus strain Guang9.
    Deng L; Fan J; Ding Y; Zhang J; Zhou B; Zhang Y; Huang B
    Oncotarget; 2017 Jun; 8(25):40533-40543. PubMed ID: 28465492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-24-Armed Oncolytic Vaccinia Virus Exerts Potent Antitumor Effects via Multiple Pathways in Colorectal Cancer.
    Deng L; Yang X; Fan J; Ding Y; Peng Y; Xu D; Huang B; Hu Z
    Oncol Res; 2021 Mar; 28(6):579-590. PubMed ID: 32641200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new recombinant vaccinia with targeted deletion of three viral genes: its safety and efficacy as an oncolytic virus.
    Yang S; Guo ZS; O'Malley ME; Yin X; Zeh HJ; Bartlett DL
    Gene Ther; 2007 Apr; 14(8):638-47. PubMed ID: 17268533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. JNK-deficiency enhanced oncolytic vaccinia virus replication and blocked activation of double-stranded RNA-dependent protein kinase.
    Hu W; Hofstetter W; Guo W; Li H; Pataer A; Peng HH; Guo ZS; Bartlett DL; Lin A; Swisher SG; Fang B
    Cancer Gene Ther; 2008 Sep; 15(9):616-24. PubMed ID: 18535619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncolytic cancer therapy with a vaccinia virus strain.
    Deng L; Fan J; Ding Y; Zhang J; Zhou B; Zhang Y; Huang B; Hu Z
    Oncol Rep; 2019 Jan; 41(1):686-692. PubMed ID: 30365140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.